Neuropace, Inc. · NASDAQ:NPCE
Morrell Martha received 5,460 Neuropace, Inc. shares as an award (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Morrell Martha (CHIEF MEDICAL OFFICER) received 5,460 Neuropace, Inc. shares as an award, leaving 52,743 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 5,460 shares
- Holding after
- 52,743 shares
- Trading plan
- No
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Award | 5,460 | 52,743 | Direct |
Source
Related
- Neuropace, Inc.
- Morrell Martha
- Neuropace, Inc. shareholders
- Form 4 · Morrell Martha · Sep 25, 2026
- Form 4 · Morrell Martha · Aug 28, 2026
- Form 4 · Morrell Martha · Jun 25, 2026
- Form 4 · Morrell Martha · May 28, 2026
- Form 4 · Williams Patrick F. · Sep 21, 2026
- Form 4 · Becker Joel · Sep 4, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Sep 4, 2026
- Form 4 · Becker Joel · Aug 28, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026